The purposes of this study were to examine a new method to determine exercise intensity for obese people based on the cardiac vagal activity and to determine the effect of this approach on myocardial stress. SUBJECTS: Forty-three middle aged obese female volunteers (age 43.7 AE 6.5 y; height 1.56 AE 0.05 m; body mass 66.5 AE 9.3 kg; body mass index 27.3 AE 2.8 kg m 2 ; percentage body fat 40.7 AE 5.9%). MEASUREMENT: In the first experiment, 43 subjects performed a ramp exercise test on a bicycle ergometer with measurement of ECG and gas exchange parameters. In the second experiment, 11 subjects performed 45 min of constant walking exercise on a treadmill at a level corresponding to exercise intensity determined by vagal activity obtained from a ramp bicycle test. Blood pressure, endothelin 1 (ET-1), catecholamine, atrial natriuretic peptide (ANP), and brain natriuretic peptide (BNP) were measured before and after exercise. RESULTS: The heart rate variability power decreased with increasing work rate, and changed little after reaching individualspecific work rate. We presumed that vagal activity disappeared at this point and that the heart rate at this exercise intensity was determined as the vagal activity threshold (T VA ). The results showed a significant positive correlation (r ¼ 0.742, P < 0.0001) between T VA and ventilatory threshold (VT) heart rates, although the mean heart rate of T VA (114.3 AE 8.5 beats=min) was significantly lower (P < 0.001) than that at VT (119.0 AE 11.7), suggesting the cardiac vagal withdrawal occurred prior to the onset of lactate acidosis (lactic acid accumulation). Furthermore, exercise intervention experiment at T VA indicated that ET-1, catecholamine and BNP levels were not significantly different before and after exercise. However, ANP levels increased significantly after exercise (pre-exercise 18.6 AE 5.38 vs post-exercise 44.0 AE 24.87 pg=ml, P < 0.001), which in turn brought about a significant post-exercise reduction in the blood pressure (SBP 117.6 AE 13.7 vs 110.5 AE 7.4 mmHg, P < 0.05; DBP 78.6 AE 6.7 vs 73.5 AE 6.6 mmHg, P < 0.01). CONCLUSION: Our data suggest that it is possible to determine the exercise intensity (T VA ) on the basis of cardiac vagal response. These results also suggest that exercise at T VA level is a safe exercise intensity in the light of cardiac stress, and that T VA may be recommended for obese people who might possess lower cardiac sympatho-vagal activity.
Introduction
Obesity has been associated with medical complications including hypertension and diabetes, as well as with an increased risk of cerebral and vascular diseases. 1 -3 It was thought that these diseases are more strongly correlated with abdominal visceral fat than subcutaneous fat. 4, 5 It may be desirable for obese people to lose abdominal visceral fat. As exercise training not only decreases abdominal visceral fat but also improves general health, it is recommended for obese people with no contraindications.
It is most important to determine the exercise intensity for a proper exercise prescription. It has been recommended that the initial exercise intensity be set at 60 -70% of maximal aerobic capacity for healthy adults, and at 40 -60% for those individuals with a lower aerobic capacity. 6, 7 In general, exercise intensity is set at a percentage of one's maximal aerobic capacity as measured by maximal oxygen uptake ( _ V VO 2max ) and=or at the onset of anaerobic metabolism with subsequent blood lactate accumulation termed as anaerobic threshold (AT) or ventilatory threshold (VT) evaluated from the viewpoint of metabolic and respiratory responses during exercise.
On the other hand, it is well known that the increase in exercise intensity causes a significant withdrawal of cardiac vagal activity. 8, 9 It is also revealed that such a decline in vagal tone has been associated with coronary heart disease and sudden cardiac death. In fact, clinical 10 as well as experimental studies 11, 12 have shown that individuals with the greatest reduction in parasympathetic tone and=or increase in sympathetic tone following a myocardial infraction also have the greatest propensity for sudden cardiac death. Thus, to perform exercise at intensity which still reserves cardiac vagal activity is expected to decrease the risk of sudden cardiac death during exercise.
Petretta et al 13 demonstrated that obese people showed a decline in cardiac sympatho-vagal activity, indicating that the body mass index (BMI: body mass (kg)=height (m) 2 ) was negatively correlated with the heart rate variability power spectral results. It was also demonstrated that the variability of ECG R-R intervals in obese women was smaller in comparison with the control group (age-matched non-obese women), which is mainly caused by depression in cardiac parasympathetic activity.
14 From the above-mentioned results, exercise recommendations should be offered in the light of sympatho-vagal activity, particularly for those individuals with obesity who might possess higher risk factors for many other complications including cardiac arrhythmia, hypertension, diabetes, hyperlipidemia etc, as well as reduced autonomic nervous system activity.
However, there have been few reports that have examined exercise intensity from a standpoint of cardiac vagal activity. Earlier studies about the estimation of cardiac sympathovagal activity have employed spectral analysis of heart rate fluctuations. 15 -17 Since the minimal time period required to estimate the sympathetic or vagal activity by spectral analysis is about 4 min, determination of the sympatho-vagal activity by this method during incremental exercise is not useful. In fact, Polanczyk et al 18 have clearly shown that spectral analysis is not capable of evaluating autonomic modulation of heart rate during exercise.
The appropriate method of analysis of the cardiac autonomic nervous activity during incremental exercise has previously been reported from our laboratory. 19 -21 In this study, we developed a more useful method for ramp exercise testing and proposed a new method for determining exercise intensity on the basis of cardiac vagal activity (T VA ). It is expected that exercise at this intensity would provide a physiologically sound and safe exercise intensity for obese people who might have a reduced vagal tone by avoiding unnecessarily high myocardial stress. The efficacy and validity of our T VA was also examined in the subsequent study in which myocardial stress was evaluated during exercise at the T VA intensity by examining the circulating hormones including catecholamines, atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), endothelin 1 (ET-1) etc and blood pressure.
Methods

Subjects
Forty-three middle-aged obese female volunteers served as subjects for this study. Subjects were premenopausal, on no medications, nonsmokers and without hypertension. All experimental procedures were explained in detail to each subject, who signed a statement of informed consent. We adopted the criterion of obesity, ie BMI above 25 kg=m 2 and=or 30% body fat for our, Japanese population according to the Japan Society for the Study of Obesity. Our subjects' physical characteristics (mean AE s. 
T VA determination
Prior to the present study, we performed pharmacological blockade of sympatho-vagal activity for six young and middle-aged male volunteers. Figure 1 shows typical data on successive differences of heart period under the pharmacological blockade of sympathetic ( Figure 1A ) and parasympathetic ( Figure 2A ) pathway performed on separate days. ECG data were obtained while subjects were in a sitting position in a chair for 25 min. Autonomic block agents were intravenously injected within 4 min of 10 min after beginning of the experiment. We used propranolol (0.2 mg=kg) for sympathetic blockade and atropine (0.04 mg=kg) as a The mean values of PO during resting control conditions were pre-sympathetic blockade and pre-parasympathetic blockade and were not statistically different. Upon the sympathetic blockade, the successive differences of heart period and the corresponding PO were significantly increased from the resting control level (407.5 AE 186.7 to 2233.4 AE 942.9 ms 2 =beat, P < 0.001) due to the suppression of the sympathetic neural drive to the heart. In contrast, the heart period acceleration -deceleration and PO were nearly abolished (438.5 AE 221.2 to 3.43 AE 0.71 ms 2 =beat, P < 0.001) upon the cardiac parasympathetic blockade, strongly suggesting that cardiac acceleration -deceleration PO largely represents cardiac vagal activity. In other words, the PO increases when cardiac vagal activity becomes predominant during the sympathetic blockade, while the PO decreases upon the vagal blockade. Figure 2 represents a typical set of data demonstrating the time course of changes in the successive differences in heart period and the PO during progressive ramp exercise test. Figure 2A shows that both parameters decrease progressively during exercise as compared with the resting condition. Figure 2B shows the expanded view for the ramp exercise involving a 2 min warm-up period. Both parameters decreased with increasing workload, and changed little after about 8 min of exercise. We presumed that vagal activity was strongly suppressed or withdrew after the point indicated by the arrow in Figure 2B . We have therefore defined the heart rate at this particular exercise intensity as vagal activity threshold (T VA ) which represents the highest workload (heart rate) sustainable at the threshold of cardiac vagal activity. T VA was clearly determined for all of our subjects in the present study as a convergent point of the PO as well as in our previous study with individuals with diabetic patients. 22 A time constant of heart rate of 35 s was included in the T VA determination as cardio-respiratory system responses with a time lag from workload changes.
Procedure
The subjects, each of whom was screened with a complete medical history and physical examination, performed a ramp exercise test on a cycle ergometer. _ V VO 2max , ventilatory threshold (VT) and vagal activity threshold (T VA ) of each subject were obtained (Experiment 1). After Experiment 1 was carried out, we asked subjects to participate in Experiment 2 in order to determine the efficacy of the exercise prescription based upon the T VA in terms of myocardial stress. Eleven of the subjects gave their consent and underwent this invasive experiment. The physical characteristics of the subjects are indicated in Table 1 .
In Experiment 2, each subject was tested before and after the experimental treatments (45 min resting control or 45 min exercise at T VA intensity) and repeated measurements of blood samples and blood pressure were obtained on two different days. On the exercise day, the subject performed a constant 45 min walking exercise on a treadmill at the intensity eliciting the individual T VA obtained from Experiment 1. We adjusted the walking speed while keeping a constant heart rate value (T VA ) for each subject by continuous monitoring of her heart rate.
Exercise test protocol
The first exercise test determined the subject's _ V VO 2max , anaerobic threshold or ventilatory threshold (VT) and T VA by use of a ramp exercise test on a stationary bicycle ergometer (STB-1350, Nihon Koden). The transition from aerobic to anaerobic metabolism has been the subject of special focus in human experiments. The level of exercise just below that at which metabolic acidosis occurs has been called the anaerobic threshold (AT). 6, 7 The physiological requirements for performing exercise above AT are considerably more Exercise intensity determined by cardiac vagal activity M Shibata et al demanding than for lower intensities. Lactic acidosis (anaerobic) threshold occurs at a metabolic rate that is specific to the individual and is usually caused by an inadequate oxygen supply. Thus, the AT can be considered to be an important assessment of the ability of the cardio-respiratory system to supply oxygen at a rate adequate to prevent muscle anaerobiosis during exercise. We measured each individual AT by gas exchange parameters, ie ventilatory threshold (VT), in this study in order to compare with T VA . Following a warm-up exercise at 30 W for 2 min, the ramp test started at a constant pedaling frequency of 60 rpm, incremented by 10 W every minute. The exercise stopped when one of the following criteria for maximal oxygen uptake was obtained: (1) a plateau or leveling off of oxygen uptake in spite of the increasing workload; (2) reaching maximal heart rate (maximal predicted heart rate AE 5%); (3) inability to maintain a speed of 60 rpm; or (4) volitional exhaustion. VT was determined independently by the authors by the criteria described by Caiozzo et al. 23 Gas exchange parameters were obtained using a breath-bybreath automated open-circuit system (AE-280S, Minato).
The electrocardiogram (ECG; amplified from CM5 lead position) was monitored during the ramp exercise test. The signal was digitized at a sampling rate of 1 kHz with 14-bit analog-to-digital conversion (PS9351, TEAC) by an on-line computer system. From the ECG data obtained, the QRS complex was detected by means of a software developed in our laboratory 24 and heart periods (R-R intervals) were calculated to a precision of 1 ms.
Body composition
Body mass was recorded by use of a scale (BWB-627, Tanita) to the nearest 100 g. Body fat mass was measured by use of dual-energy X-ray absorbtiometry (XR-26, Norland), and percentage body fat calculated.
Blood analysis
For plasma ANP and BNP measurements, 5 ml of blood were aspirated into a polypropylene tube containing 4.5 mg of EDTA-2Na and 150 ml of tradiol. The sampled blood was immediately ice-cooled and centrifuged at 3000 rpm for 10 min at 4 C, thereby separating the plasma, which was maintained at 770 C until the day of analysis. Plasma ANP and BNP concentrations were measured with an immunoradiometric assay (IRMA; Shionoria ANP and BNP) using two monoclonal antibodies. Plasma catecholamine (Catecholamine Assay Reagents, Tosoh, Japan) and endothelin-I (ET-1; Sumitomo Metal Bioscience, Japan) concentrations were determined by radioimmunoassay.
Statistical analysis
Results are expressed as mean AE s.d. Pearson's correlation coefficient (r) was calculated to determine correlation. The paired t-test, when applicable, was performed to compare the mean values among the respective conditions. In all analyses, differences were considered significant at P < 0.05.
Results
Experiment 1
In the V O 2max test, most of the subjects stopped the exercise due to volitional exhaustion before reaching a plateau of oxygen uptake or maximal heart rate. The mean of peak V O 2 and VT of all subjects (n ¼ 43) was 21.8 AE 2.8 and 14.1 AE 2.0 ml=kg=min, respectively. The mean value of T VA was 114.3 AE 8.5 beats=min and PO at T VA was 3.71 AE 2.54 ms 2 =beat. Figure 3 shows the relationship between heart rate at VT (VT-HR) and T VA . There was a highly significant positive correlation between VT-HR and T VA (r ¼ 0.742, P < 0.0001). However, the mean value of T VA was significantly smaller than VT-HR (114.3 AE 8. vs 119.0 AE 11.7 beats=min, P < 0.001). Similarly, the mean in T VA of subjects who participated in Experiment 2 was also significantly smaller than VT-HR (122.3 AE 8.7 vs 127.3 AE 11.3, P < 0.02). These data indicated the possibility that the severe suppression and=or withdrawal of the cardiac vagal activity occurred at significantly lower exercise intensity than the anaerobic threshold.
Experiment 2
In Experiment 2, we examined the effects of exercise at T VA level on blood pressure, fluid-regulating hormones (ANP and BNP), ET-1 and catecholamine levels. Figure 3 Relationship between T VA and heart rate at ventilatory threshold (n ¼ 43).
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Results indicated that blood pressures measured before and immediately after the 45 min resting control showed nearly identical values (SBP, 118.2 AE 14.0 vs 117.5 AE 14.2 mmHg, P > 0.05; DBP, 78.0 AE 7.7 vs 77.5 AE 7.82 mmHg, P > 0.05). There were, however, significant reductions in blood pressure after walking exercise at T VA (SBP, 117.6 AE 13.7 vs 110.5 AE 7.4 mmHg, P < 0.05; DBP, 78.6 AE 6.7 vs 73.5 AE 6.6 mmHg, P < 0.01) compared to the pre-treatment control condition. Table 2 indicates mean concentrations of ET-1, catecholamines (adrenaline, noradrenaline and dopamine), ANP and BNP before and after a 45 min walking exercise at T VA and resting control conditions. The mean value of ET-1, catecholamine and BNP were not significantly different before and after in any experimental condition. On the other hand, the mean value of ANP after the walking exercise increased significantly (pre-exercise 18.6 AE 5.38 vs post-exercise 44.0 AE 24.87 pg=ml, P < 0.001), while no such changes were observed during the 45 min resting condition (pre-rest 14.0 AE 3.97, post-rest 12.9 AE 4.38 pg=ml, P > 0.05).
Discussion
The reduction in autonomic activity in obesity was confirmed in the studies using the methods of endocrine 25 and heart rate variability power spectral analysis. 13 Although the precise mechanisms responsible for the derangement in cardiac electrical activity that leads to ventricular fibrillation are unknown at present, myocardial ischemia and subsequent alterations or disturbances in the autonomic neural control of the heart could play a critical role in the development of ventricular fibrillation. 10 -12 These studies suggest that activation of the sympathetic nervous system tends to reduce the electrical stability of the heart, whereas parasympathetic nerve stimulation can protect against malignant arrhythmias. Furthermore, clinical 10 as well as experimental studies 11, 12 have shown that individuals with the greatest reduction in parasympathetic tone and=or increase in sympathetic tone following a myocardial infarction also have the greatest propensity for sudden cardiac death.
In the light of these studies, it might be reasonable to assume that obese individuals are likely to possess a much reduced autonomic nervous system including the cardiac sympatho-vagal functions which in turn expose them to such cardiac sudden death to a much greater extent than those of sedentary individuals during exercise. For this reason, we have attempted to determine exercise intensity from the viewpoint of cardiac vagal activity in the present study. Akselrod et al 15 have shown a metronome-like heartbeat with blockade of vagal and sympathetic pathway. That is, very little heart rate fluctuation would exist under abolished autonomic activity. In fact, the mean PO in this study was 3.43 AE 0.71 ms 2 =beat (converting from PO to successive difference by taking the square root of 3.43 is only 1.85 ms) with pharmacological blockade of vagal activity. Thus, it can be assumed that a highly depressed PO activity reflects the disappearance of vagal activity, and that PO obtained from successive difference in R-R intervals might be an indicator of cardiac vagal activity.
In our study, the mean value of PO decreased with progressive increases in exercise intensity and changed little after reaching a specific exercise intensity. T VA was determined as heart rate at the point where PO changed little and became nearly constant despite further increases in work rate. The mean PO at T VA was 3.71 AE 2.54 ms 2 =beat (equivalent to R-R interval difference of 1.93 ms), which was almost identical to those observed during pharmacological blockade of the parasympathetic nervous system. These data suggest that T VA was the critical exercise intensity above which the cardiac parasympathetic activity was totally suppressed. Our present data have clearly shown that it is quite possible to determine the critical exercise intensity (T VA ) based upon each individual cardiac parasympathetic activity, which can then be offered to those individuals with obesity who might possess higher risk factors for many other complications including cardiac arrhythmia, hypertension, diabetes, hyperlipidemia etc, as well as reduced autonomic nervous system activity.
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Estimations of myocardial stress were made by examining the circulating hormones including atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), endothelin 1 (ET-1), etc. ANP and BNP exhibit a wide range of potent vasodilatation. 26 -28 Plasma concentration of ANP increases with exercise while BNP concentrations increase strikingly with exercise in patients with old myocardial infarction, but change little in normal subjects. 29 Therefore, BNP may be a good marker for cardiac stress. 30 Also, since the increase in myocardial stress relates to exercise-induced vasoconstriction, we measured the levels of ET-1 (a potent vasoconstrictor) and blood pressure. Our results indicated that there were only minor changes in endocrine secretion before and after 45 min walking at T VA ; however, ANP concentration demonstrated a significant increase after exercise. It is generally accepted that ANP is a circulating hormone with a wide range of potent biological effects, including vasodilation, natriuresis, diuresis and inhibition of the renin-angiotensin-aldosterone system 26, 27 and the sympathetic system. 28 It is also known that patients with chronic congestive heart failure have greater plasma ANP levels compared with normal individuals and that there is a liner relation between plasma ANP levels and atrial pressure. 31 -33 This implies that atrial pressure or stretch plays an important role in the regulation of secretion of ANP. Saito et al 34 have shown that infusion of ANP improves left ventricular function by reducing both preload and afterload in patients with heart failure. Thus the increase in ANP seen during exercise is most likely to decrease the plasma volume 35 and plays a role as vasodilator. As a result, we found that the mean values of both systolic and diastolic blood pressure after 45 min walking exercise decreased significantly compared with those taken during the control resting condition.
On the other hand, a strong vasoconstrictor substance ET-1 showed no such significant changes before and after exercise. Maeda et al 36 have demonstrated that ET-1 was markedly increased immediately after exercise at a 130% VT level compared with that at 90% VT. Considering that T VA corresponds to a level below the VT level, the present result of no change in ET-1 by exercise at T VA is in good agreement with this earlier report. 36 Thus, it is thought that the increase in ANP and non-production of ET-1 contributes to the moderate hypotensive effect in response to acute effects of exercise at T VA level.
Incidentally, reduced vagal activity is one of the risk factor for cardiac sudden death and other complications. 10 In this study, T VA was determined as exercise intensity of a relatively suppressed, but still active vagal activity. It is known that increased release of plasma catecholamines correlates with the increase in the activity of the sympathetic nervous system. The finding of no significant change in plasma catecholamine during a 45 min walking exercise at the T VA level in this study suggests that there was no significant activation of the sympathetic nervous system during exercise at this level. In addition, there is also no change in plasma BNP concentration during exercise at T VA level. BNP has potent biological effects, including vasodilation, natriuresis, diuresis, and inhibition of the renin -angiotensin -aldosterone system as well as ANP. Plasma concentrations of ANP increase with exercise. 37, 38 However, exercise-induced BNP concentrations increase strikingly in patients with old myocardial infarction, 29 congestive heart failure 39 and hypertension, 38 but change little in normal subjects. 29, 38, 39 Morita et al 30 have also demonstrated that the increase in BNP levels is greater than ANP levels in patients with acute myocardial infarction, and concluded that the contribution of BNP to compensation of left ventricular dysfunction may be much greater than that of ANP. From these reports, it is presumed that the increase in exercise-induced BNP concentration reflects augmented myocardial stress. Accordingly, our finding of small and no significant changes in the plasma BNP concentration by exercise at T VA level supports the concept that the work rate at T VA elicits ANP, but is not severe enough to cause myocardial stress-induced BNP secretion in apparently health obese individuals.
In summary, our results demonstrate that it is possible to determine exercise intensity (T VA ) on the basis of cardiac vagal activity. Our data also suggest that exercise at the T VA level is safe, without eliciting high myocardial stress, and therefore can be recommended for individuals who have lower cardiac sympatho-vagal activity, including obese people.
